Evidence map›Paper›PMID 42808090›Full record

ArticleJCO oncology advances

Episodic Future Thinking: A Behavioral Intervention to Promote Weight Loss in Breast Cancer Survivors (Alliance A21-Pilot10).

Jasmine S Sukumar, Maryam B Lustberg, Jeffrey Stein, Patrick M Schnell, Jenna King, Denise Schimming, Rachee Hatfield, Dionisia Quiroga, Ashley Davenport, Margaret E Gatti-Mays and 7 more

Abstract read
In one paragraph

Article in JCO oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jasmine S SukumarDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-6994-8527
Maryam B LustbergDivision of Medical Oncology, Department of Internal Medicine, Yale Comprehensive Cancer Center, New Haven, CT.ORCID 0000-0001-8559-5645
Jeffrey SteinFraling Biomedical Research Institute, Virginia Tech, Roanoke, VA.ORCID 0000-0001-5251-3447
Patrick M SchnellThe Ohio State University College of Public Health, Columbus, OH.ORCID 0000-0002-2343-208X
Jenna KingDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Denise SchimmingDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Rachee HatfieldDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0009-0006-6361-1484
Dionisia QuirogaDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0003-3388-7069
Ashley DavenportDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0002-7993-6316
Margaret E Gatti-MaysDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0001-8914-2897
Nicole O WilliamsDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Mathew A CherianDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0002-0380-2012
Daniel G StoverDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0001-9003-8165
Robert WesolowskiDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0003-0606-0648
Karen M Basen-EngquistDepartment of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-7299-0646
Jennifer VaughnDivision of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Sagar SardesaiDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.

Funding

Collaborations and NCORP Collective ManagementUG1CA189823 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis, Olwen Hahn · 2014 to 2026
$120.6M
Transdisciplinary Research in Energetics and Cancer (TREC) Training GrantR25CA203650 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L · 2016 to 2025
$2.9M
UTMB Women's Health Research Scholars ProgramK12AR084228 · NIAMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ABBEY B BERENSON · 2023 to 2026
$2.7M
NCI NIH HHS R25 CA203650NCI NIH HHS UG1 CA189823NIAMS NIH HHS K12 AR084228
6 · The paper itself

Abstract

purposeObesity in breast cancer survivors (BCS) increases mortality, but lifestyle interventions have mixed outcomes. Episodic future thinking (EFT), in which individuals mentally simulate positive personal future-oriented events, has shown to reduce body weight (BW) and delay discounting (DD; the tendency to value delayed rewards less). How EFT affects BW reductions in BCS is unknown. This phase II trial evaluated the feasibility and preliminary efficacy of EFT in reducing BW in BCS with overweight/obesity.

methodsWomen with nonmetastatic BC who completed treatment with a BMI ≥25 kg/m

resultsWe included 46 participants; 17/23 (74%) in EFT and 19/23 (83%) in ERT completed the intervention; 83% had low baseline DD (<0.0025). EFT adherence approached the 80% target to establish feasibility (EFT, 77% [95% CI, 0.69 to 0.85]). ERT had similarly high adherence (82% [95% CI, 78 to 86]). BW decreased overall (-2.01% [95% CI, -3.06 to -0.97];

conclusionA telehealth delivered behavioral intervention for weight loss is feasible in BCS, demonstrated by high participant adherence. Additional research is needed to elucidate EFT as well as ERT's comparable role in modulating DD and as an adjunct to lifestyle interventions for weight loss in BCS.

Identifiers

PMID42808090
PMCPMC13618992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.